LeMaitre Vascular (LMAT) Stock Price, News & Analysis

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LeMaitre Vascular in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" LMAT shares.
View LMAT analyst ratings or view top-rated stocks.

7 brokerages have issued 1 year price targets for LeMaitre Vascular's shares. Their LMAT share price targets range from $67.00 to $79.00. On average, they expect the company's share price to reach $73.83 in the next twelve months. This suggests that the stock has a possible downside of 1.5%.
View analysts price targets for LMAT or view top-rated stocks among Wall Street analysts.

LeMaitre Vascular's stock was trading at $56.76 on January 1st, 2024. Since then, LMAT shares have increased by 32.1% and is now trading at $74.98.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 6th 2024.
View our LMAT earnings forecast.

LeMaitre Vascular, Inc. (NASDAQ:LMAT) released its quarterly earnings results on Thursday, May, 2nd. The medical instruments supplier reported $0.44 EPS for the quarter, beating the consensus estimate of $0.39 by $0.05. The medical instruments supplier earned $53.48 million during the quarter, compared to analysts' expectations of $51.50 million. LeMaitre Vascular had a trailing twelve-month return on equity of 11.57% and a net margin of 16.99%. The firm's revenue was up 13.6% compared to the same quarter last year. During the same period last year, the firm earned $0.27 EPS.

LeMaitre Vascular declared a quarterly dividend on Tuesday, April 30th. Investors of record on Thursday, May 16th will be given a dividend of $0.16 per share on Thursday, May 30th. This represents a $0.64 annualized dividend and a yield of 0.85%. The ex-dividend date is Wednesday, May 15th.
Read our dividend analysis for LMAT.

LeMaitre Vascular (NASDAQ:LMAT) pays an annual dividend of $0.64 per share and currently has a dividend yield of 0.96%. The company has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 42.38%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, LMAT will have a dividend payout ratio of 34.59% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for LMAT.

ETFs with the largest weight of LeMaitre Vascular (NASDAQ:LMAT) stock in their portfolio include Small Cap US Equity Select ETF (RNSC), Janus Henderson Small Cap Growth Alpha ETF (JSML), Pacer US Small Cap Cash Cows Growth Leaders ETF (CAFG), Invesco S&P SmallCap Health Care ETF (PSCH), Invesco Dorsey Wright Healthcare Momentum ETF (PTH) and iShares Micro-Cap ETF (IWC).iShares U.S. Medical Devices ETF (IHI).

LeMaitre Vascular issued an update on its second quarter 2024 earnings guidance on Friday, May, 3rd. The company provided EPS guidance of 0.450-0.500 for the period, compared to the consensus EPS estimate of 0.440. The company issued revenue guidance of $53.7 million-$56.1 million, compared to the consensus revenue estimate of $54.3 million.

13 employees have rated LeMaitre Vascular Chief Executive Officer George W. LeMaitre on Glassdoor.com. George W. LeMaitre has an approval rating of 33% among the company's employees. This puts George W. LeMaitre in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other LeMaitre Vascular investors own include AbbVie (ABBV), Sociedad Química y Minera de Chile (SQM), Gilead Sciences (GILD), Aurora Cannabis (ACBFF), NVIDIA (NVDA), Adobe (ADBE), Boeing (BA) and Salesforce (CRM).

LeMaitre Vascular's stock is owned by many different retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (8.61%), Geneva Capital Management LLC (4.01%), Congress Asset Management Co. MA (2.99%), Russell Investments Group Ltd. (1.27%), Rice Hall James & Associates LLC (1.04%) and Mesirow Institutional Investment Management Inc. (0.63%). Insiders that own company stock include Bridget A Ross, David B Roberts, George W Lemaitre, John A Roush, Joseph P Pellegrino Jr, Lawrence J Jasinski and Trent G Kamke.
View institutional ownership trends.

Shares of LMAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.